Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

10.8K
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
10.8K
Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
What is the Immune System?01:38

What is the Immune System?

139.9K
Overview
139.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.4K
Overview
85.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype.

Nature communications·2026
Same author

New approaches for UK-China global health cooperation.

Lancet (London, England)·2026
Same author

Targeting the cGAS-STING pathway for therapeutic gain in autoimmune inflammatory cutaneous diseases with a focus on systemic lupus erythematosus and systemic sclerosis.

The British journal of dermatology·2025
Same author

Pathogenic variants in the cohesin loader subunit MAU2 lead to a new Cornelia de Lange Syndrome subtype.

medRxiv : the preprint server for health sciences·2025
Same author

The Role of the Pulmonary Microenvironment in Driving Transition From Systemic Sclerosis to Systemic Sclerosis-Associated Interstitial Lung Disease.

The Journal of rheumatology·2025
Same author

A Long Stretch: IL-11 Drives Skin Regeneration.

The Journal of investigative dermatology·2025

Related Experiment Video

Updated: Mar 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K

Innate Immunity in Systemic Sclerosis.

Christopher Dowson1, Nathan Simpson1, Laura Duffy1

  • 1Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Ellison Building, Newcastle Upon Tyne, NE2 8ST, UK.

Current Rheumatology Reports
|January 25, 2017
PubMed
Summary

Systemic sclerosis involves innate immune dysregulation, particularly toll-like receptor (TLR) signaling, contributing to disease progression. Targeting these innate immune pathways offers a potential therapeutic strategy for systemic sclerosis.

Keywords:
Autoimmune diseaseSScSclerodermaSystemic sclerosis

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

941

Related Experiment Videos

Last Updated: Mar 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

941

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vasculopathy, autoantibodies, and fibroblast dysfunction.
  • The precise etiology of SSc remains unclear due to intricate cellular signaling pathways.
  • The innate immune system, especially toll-like receptor (TLR) signaling, is increasingly implicated in SSc onset and progression.

Purpose of the Study:

  • To review the role of innate immunity in systemic sclerosis (SSc).
  • To explore the contribution of toll-like receptor (TLR) signaling in SSc pathogenesis.
  • To suggest potential therapeutic targets within the innate immune system for SSc.

Main Methods:

  • Literature review of studies investigating innate immunity in systemic sclerosis.
  • Analysis of evidence linking toll-like receptor (TLR) signaling to SSc.
  • Examination of endogenous ligands and sterile inflammation in SSc.

Main Results:

  • Toll-like receptors (TLRs) are dysregulated in systemic sclerosis (SSc).
  • Elevated endogenous ligands contribute to 'sterile inflammation' and fibrosis in SSc.
  • Innate immune dysregulation is a key factor in SSc pathogenesis.

Conclusions:

  • Innate immune system dysregulation, particularly TLR signaling, is central to systemic sclerosis (SSc).
  • Targeting innate immune perturbations represents a promising novel therapeutic avenue for SSc.
  • Further research into innate immunity may lead to effective treatments for systemic sclerosis.